CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Lunit Study Links Spatial Immune Patterns to Immunotherapy Response in Bladder Cancer

By Public Technologies
  • Lunit will present two AI-powered pathology studies on ovarian and bladder cancers Nov. 7 at SITC 2026 in Phoenix.
  • The Labcorp collaboration found higher tumor cell proliferation in ovarian cancers with homologous recombination deficiency than in those without it.
  • The CellCarta study linked greater immune infiltration and closer tumor–T cell proximity to atezolizumab response in muscle-invasive bladder cancer.
  • The bladder cancer findings suggest spatial immune patterns could help identify predictive biomarkers, but require further investigation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunit Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN88717) on November 04, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk